Table 2.
Microbiologic Data
| Test | n (%), Patients (n:140) |
|---|---|
| Sputum culture obtained | 72 (51.4) |
| Growth detected | 33 (45.8) |
| Pseudomonas aeruginosa | 11 (33.3) |
| Haemophilus influenzae | 8 (24.2) |
| Streptococcus pneumoniae | 4 (12.1) |
| MSSA | 1 (3.0) |
| Othersa | 3 (9.0) |
| Polymicrobialb | 6 (18.0) |
| Nasopharyngeal swab obtained | 51 (36.4) |
| Positivec | 20 (39.2) |
| Influenza virus | 10 (50.0) |
| Rhinovirus | 2 (10.0) |
| Blood Culture | 95 (67.8) |
| Streptococcus pneumoniae | 2 (20.0) |
| Pseudomonas aeruginosa | 1 (10.0) |
| CoNS | 7 (70.0) |
| Bronchoalveolar lavage fluid Culture | 7 (5) |
| MTC Pseudomonas aeruginosa |
1 (14) 3 (52) |
| Pneumocystis jirovecii + CMV DNA | 1 (14) |
| Pleural Fluid Culture | |
| MTC | 1 (14) |
Notes: a Nocardia spp., Acinetobacter spp., Alcaligenes faecalis. b Pseudomonas aeruginosa+ Klebsiella pneumoniae; Klebsiella pneumoniae+ Streptococcus pneumoniae; MSSA+ Haemophilus influenzae; MSSA+ Pseudomonas aeruginosa+Escherichia.coli; Pseudomonas aeruginosa+ Enterobacter spp.; MSSA+Pseudomonas aeruginosa. cOthers; n:8 (40%).
Abbrviations: MSSA; Methicillin sensitive Staphylococcus aureus, CoNS; Coagulase negative staphylococci, MTC; Mycobacterium tuberculosis complex.